Why the study?
Does a verapamil-trandolapril-based strategy improve clinical effectiveness compared to an atenolol-hydrochlorothiazide-based strategy in hypertensive CAD patients?
Does a verapamil-trandolapril-based strategy improve clinical effectiveness compared to an atenolol-hydrochlorothiazide-based strategy in hypertensive CAD patients?
A verapamil-trandolapril-based strategy is as clinically effective as an atenolol-hydrochlorothiazide-based strategy in patients with hypertension and coronary artery disease.
Supports equivalence of verapamil-trandolapril and atenolol-hydrochlorothiazide strategies in hypertensive CAD; leaves open randomized confirmation.
The verapamil-trandolapril-based strategy was as clinically effective as the atenolol-hydrochlorothiazide-based strategy in hypertensive CAD patients.
No takes yet. Share an insight, caveat, or question.
Pepine et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: